当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 现金流量表

美康生物

(300439)

  

流通市值:29.38亿  总市值:38.62亿
流通股本:2.92亿   总股本:3.84亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金388,623,587.911,466,908,974.911,303,354,569.38860,677,123.23
  收到的税费返还598,361.015,527,780.563,627,097.1368,961.46
  收到其他与经营活动有关的现金11,927,770.1795,155,169.5988,163,317.5379,610,740.64
  经营活动现金流入小计401,149,719.091,567,591,925.061,395,144,984.04940,356,825.33
  购买商品、接受劳务支付的现金260,140,790.01625,793,258.07713,398,121.97473,111,941.7
  支付给职工以及为职工支付的现金116,454,244.13368,107,760.72288,575,270.61208,789,868.37
  支付的各项税费28,261,825.0395,386,596.8278,669,870.7855,689,250.92
  支付其他与经营活动有关的现金54,117,111.26211,689,398.5169,523,975.73106,479,848.75
  经营活动现金流出小计458,973,970.431,300,977,014.111,250,167,239.09844,070,909.74
  经营活动产生的现金流量净额-57,824,251.34266,614,910.95144,977,744.9596,285,915.59
二、投资活动产生的现金流量:
  收回投资收到的现金205,000,000973,284,944.25703,000,000516,000,000
  取得投资收益收到的现金1,169,213.6321,217,025.9719,478,222.719,211,494.74
  处置固定资产、无形资产和其他长期资产收回的现金净额-5,189,322.5101,041.5575,594.34
  处置子公司及其他营业单位收到的现金净额-363,080.44584,944.25-
  收到的其他与投资活动有关的现金--0-
  投资活动现金流入小计206,169,213.631,000,054,373.16723,164,208.45535,787,089.08
  购建固定资产、无形资产和其他长期资产支付的现金18,657,535.89191,407,877.1976,382,180.8564,682,728.27
  投资支付的现金195,288,0001,067,000,000796,999,900539,999,900
  取得子公司及其他营业单位支付的现金--0-
  投资活动现金流出小计213,945,535.891,258,407,877.19873,382,080.85604,682,628.27
  投资活动产生的现金流量净额-7,776,322.26-258,353,504.03-150,217,872.4-68,895,539.19
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,694,000480,000480,000
  其中:子公司吸收少数股东投资收到的现金-480,000480,000480,000
  取得借款收到的现金-34,844,668.060-
  收到其他与筹资活动有关的现金-02,214,0002,214,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-37,538,668.062,694,0002,694,000
  偿还债务支付的现金20,000,00045,000,00030,000,00030,000,000
  分配股利、利润或偿付利息支付的现金85,510.4751,992,779.5452,851,878.9430,396,853.19
  支付其他与筹资活动有关的现金-17,258,666.6110,340,066.18,337,046.53
  筹资活动现金流出小计20,085,510.47114,251,446.1593,191,945.0468,733,899.72
  筹资活动产生的现金流量净额-20,085,510.47-76,712,778.09-90,497,945.04-66,039,899.72
四、汇率变动对现金及现金等价物的影响-203,657.26-725,233.89-487,295.89-390,807.3
五、现金及现金等价物净增加额-85,889,741.33-69,176,605.06-96,225,368.38-39,040,330.62
  加:期初现金及现金等价物余额657,438,431.29726,615,036.35726,615,036.35726,615,036.35
  期末现金及现金等价物余额571,548,689.96657,438,431.29630,389,667.97687,574,705.73
补充资料:
  净利润-61,361,976.78-55,608,076.33
  资产减值准备-39,755,116.04-3,708,061.03
  固定资产和投资性房地产折旧-143,604,664.9-70,232,741.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-143,604,664.9-70,232,741.92
  无形资产摊销-14,273,559.95-6,905,974.6
  长期待摊费用摊销-13,070,723.67-9,908,798.46
  处置固定资产、无形资产和其他长期资产的损失--1,659,738.98--6,305.93
  固定资产报废损失-302,302.1-229,450.91
  公允价值变动损失--430,440.4--226,892.6
  财务费用-2,685,101.12-534,208.34
  投资损失--8,724,190.36--2,342,205.59
  递延所得税--31,091,798.66--17,382,798.1
  其中:递延所得税资产减少--11,815,798.23--11,788,040.4
    递延所得税负债增加--19,276,000.43--5,594,757.7
  存货的减少-33,853,414.88-34,237,850.25
  经营性应收项目的减少--64,039,601.58--29,650,474.1
  经营性应付项目的增加-41,606,677.94--42,018,634.9
  其他-7,133,388.68--1,096,138.72
  不涉及现金收支的投资和筹资活动金额其他项目-2,942,225.82--
  现金的期末余额-657,438,431.29-687,574,705.73
  减:现金的期初余额-726,615,036.35-726,615,036.35
  现金及现金等价物的净增加额--69,176,605.06--39,040,330.62
公告日期2026-04-292026-04-292025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑